News
ARS Pharmaceuticals (SPRY) announced that its licensing partners in China, Japan and Australia have filed for approval of neffy epinephrine nasal spray 2 mg in their respective countries. neffy 2 ...
ARS Pharmaceuticals, Inc. announced that its licensing partners in China, Japan, and Australia have applied for approval of neffy® (epinephrine nasal spray) 2 mg, which is already approved in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback